Ident. | Authors (with country if any) | Title |
---|
002531 (2014) |
Waka Yokoyama [Japon] ; Kazuki Takada [Japon] ; Nobuyuki Miyasaka [Japon] ; Hitoshi Kohsaka [Japon] | Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis |
002833 (2013) |
Kristian Thorlund [Canada] ; Eric Druyts [Canada] ; J Antonio Avi A-Zubieta [Canada] ; Ping Wu [Canada] ; Edward J. Mills [Canada] | Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings |
002834 (2013) |
Daniel E. Furst [États-Unis] ; Edward Clark Keystone [Canada] ; Alexander K. So [États-Unis, Canada, Allemagne, Pays-Bas, Italie, Royaume-Uni, Autriche] ; Jürgen Braun [Allemagne] ; Ferry C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Italie] ; Fabrizio De Benedetti [Allemagne] ; Thomas Dörner [Allemagne] ; Paul Emery [Royaume-Uni] ; Roy Fleischmann [États-Unis] ; Allan Gibofsky [États-Unis] ; J R Kalden [Allemagne] ; Arthur Kavanaugh [États-Unis] ; Bruce Kirkham [Royaume-Uni] ; Philip Mease [États-Unis] ; A. Rubbert-Roth [Allemagne] ; Joachim Sieper [Allemagne] ; Nora G. Singer [États-Unis] ; Josef S. Smolen [Autriche] ; Piet L C M. Van Riel [Pays-Bas] ; Michael H. Weisman [États-Unis] ; Kevin L. Winthrop [États-Unis] | Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012 |
002835 (2013) |
Edith Villeneuve [Canada] ; Boulos Haraoui [Canada] | Uncoupling of disease activity and structural damage. Does it matter clinically? |
002837 (2013) |
Mai Tt Nguyen [Danemark] ; Jan P Denphant [Danemark] ; Pernille Ravn [Danemark] | Three cases of severely disseminated Staphylococcus aureus infection in patients treated with tocilizumab |
002838 (2013) |
Samantha Louise Smith [Royaume-Uni] ; Darren Plant [Royaume-Uni] ; Stephen Eyre [Royaume-Uni] ; Anne Barton [Royaume-Uni] | The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis |
002839 (2013) |
Maxime Dougados [France] ; Valérie Devauchelle-Pensec [France] ; Jean François Ferlet [France] ; Sandrine Jousse-Joulin [France] ; Maria-Antonietta D'Agostino [France] ; Marina Backhaus [Allemagne] ; Jacques Bentin [Belgique] ; Gérard Chalès [France] ; Isabelle Chary-Valckenaere [France] ; Philip Conaghan [Royaume-Uni] ; Richard J. Wakefield [Royaume-Uni] ; Frédéric Etcheparre [France] ; Philippe Gaudin [France] ; Walter Grassi [Italie] ; Désirée Van Der Heijde [Pays-Bas] ; Xavier Mariette [France] ; Esperanza Naredo [Espagne] ; Marcin Szkudlarek [Danemark] | The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound |
002840 (2013) |
Mark C. Genovese [États-Unis] ; Roy M. Fleischmann [États-Unis] ; Maria Greenwald [États-Unis] ; Julie Satterwhite [États-Unis] ; Melissa Veenhuizen [États-Unis] ; Li Xie [États-Unis] ; Pierre-Yves Berclaz [États-Unis] ; Stephen Myers [États-Unis] ; Olivier Benichou [États-Unis] | Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors |
002842 (2013) |
Daniel Aletaha [Autriche] ; Farideh Alasti [Autriche] ; Josef S. Smolen [Autriche] | Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients |
002846 (2013) |
Sarah L. Mackie [Royaume-Uni] ; Christian D. Mallen [Royaume-Uni] | Polymyalgia rheumatica |
002847 (2013) |
Shunsuke Mori [Japon] ; Yukitaka Ueki [Japon] ; Yukihiro Akeda [Japon] ; Naoyuki Hirakata [Japon] ; Motohiro Oribe [Japon] ; Yoshiki Shiohira [Japon] ; Toshihiko Hidaka [Japon] ; Kazunori Oishi [Japon] | Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy |
002851 (2013) |
Bernard Combe [France] ; Ronald Van Vollenhoven [Suède] | Novel targeted therapies: the future of rheumatoid arthritis? Mavrilumab and tabalumab as examples |
002852 (2013) |
Jessy Présumey [France] ; Gabriel Courties [France] ; Pascale Louis-Plence [France] ; Virginie Escriou [France] ; Daniel Scherman [France] ; Yves-Marie Pers [France] ; Hans Yssel [France] ; Jérôme Pène [France] ; Diego Kyburz [Suisse] ; Steffen Gay [Suisse] ; Christian Jorgensen [France] ; Florence Apparailly [France] | Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis |
002853 (2013) |
Maarten Boers [Pays-Bas] ; Lilian Van Tuyl [Pays-Bas] ; Marianne Van Den Broek [Pays-Bas] ; Piet J. Kostense [Pays-Bas] ; Cornelia F. Allaart [Pays-Bas] | Meta-analysis suggests that intensive non-biological combination therapy with step-down prednisolone (COBRA strategy) may also ‘disconnect’ disease activity and damage in rheumatoid arthritis |
002854 (2013) |
Carrie L. Wagner [États-Unis] ; Sudha Visvanathan [États-Unis] ; Michael Elashoff [États-Unis] ; Iain B. Mcinnes [Royaume-Uni] ; Philip J. Mease [États-Unis] ; Gerald G. Krueger [États-Unis] ; Frederick T. Murphy [États-Unis] ; Kim Papp [Canada] ; Juan J. Gomez-Reino [Espagne] ; Michael Mack [États-Unis] ; Anna Beutler [Canada] ; Dafna Gladman [Canada] ; Arthur Kavanaugh [États-Unis] | Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab |
002855 (2013) |
C. Malattia [Italie] ; A. Consolaro [Italie] ; S. Pederzoli [Italie] ; A. Madeo [Italie] ; A. Pistorio [Italie] ; M. Mazzoni [Italie] ; C. Mattiuz [Italie] ; Gm Magnano [Italie] ; S. Viola [Italie] ; A. Buoncompagni [Italie] ; E. Palmisani [Italie] ; R. Hasija [Italie] ; N. Ruperto [Italie] ; A. Ravelli [Italie] ; A. Martini [Italie] | MRI versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in juvenile idiopathic arthritis |
002856 (2013) |
Charles Peterfy [États-Unis] ; Mikkel Stergaard [Danemark] ; Philip G. Conaghan [Royaume-Uni] | MRI comes of age in RA clinical trials |
002858 (2013) |
John J. O'Shea [États-Unis] ; Apostolos Kontzias [États-Unis] ; Kunihiro Yamaoka [Japon] ; Yoshiya Tanaka [Japon] ; Arian Laurence [États-Unis] | Janus kinase inhibitors in autoimmune diseases |
002859 (2013) |
Stephanie Finzel [Allemagne] ; Juergen Rech [Allemagne] ; Sarah Schmidt [Allemagne] ; Klaus Engelke [Allemagne] ; Matthias Englbrecht [Allemagne] ; Georg Schett [Allemagne] | Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study |
002861 (2013) |
Yvonne C. Lee [États-Unis] ; Bing Lu [États-Unis] ; Gilles Boire [Canada] ; Boulos Paul Haraoui [Canada] ; Carol A. Hitchon [Canada] ; Janet E. Pope [Canada] ; J Carter Thorne [Canada] ; Edward Clark Keystone [Canada] ; Daniel H. Solomon [États-Unis] ; Vivian P. Bykerk [États-Unis, Canada] | Incidence and predictors of secondary fibromyalgia in an early arthritis cohort |
002864 (2013) |
Philip G. Conaghan [Royaume-Uni] ; Patrick Durez [Belgique] ; Rieke E. Alten [Allemagne] ; Gerd-Rüdiger Burmester [Allemagne] ; Paul P. Tak [Pays-Bas, Royaume-Uni] ; Lars Klareskog [Suède] ; Anca Irinel Catrina [Suède] ; Julie Dicarlo [États-Unis] ; Corine Gaillez [France] ; Manuela Le Bars [France] ; Xianhuang Zhou [États-Unis] ; Charles Peterfy [États-Unis] | Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial |